Akarawut W, Smith D E
College of Pharmacy, University of Michigan, Ann Arbor 48109-0504, USA.
J Pharmacokinet Biopharm. 1998 Jun;26(3):269-87. doi: 10.1023/a:1023281325479.
The mechanism of quinapril's interaction with the organic anion transporter was characterized by studying its effect on the transport of p-aminohippurate (PAH) in rabbit renal basolateral membrane vesicles (BLMV). Cis-inhibition studies demonstrated that quinapril was a specific and potent inhibitor of PAH. The Ki of quinapril was about 20 microM, a value similar to that of probenecid and eight-times lower than the K(m) value of 165 microM for PAH. Even though quinapril resulted in trans-inhibition of PAH uptake during counterflow studies, kinetic studies revealed that quinapril was a competitive inhibitor of PAH transport. This latter findings suggests that quinapril and PAH share a common binding site on the transporter. Overall, the results indicate that quinapril is a high-affinity inhibitor of the organic anion transporter in renal BLMV, and that drug-drug interactions may occur with other organic anions at the basolateral membrane of proximal cells.
通过研究喹那普利对兔肾基底外侧膜囊泡(BLMV)中对氨基马尿酸(PAH)转运的影响,对其与有机阴离子转运体的相互作用机制进行了表征。顺式抑制研究表明,喹那普利是PAH的特异性强效抑制剂。喹那普利的Ki约为20μM,该值与丙磺舒相似,比PAH的165μM的K(m)值低八倍。尽管在逆流研究中喹那普利导致PAH摄取的反式抑制,但动力学研究表明喹那普利是PAH转运的竞争性抑制剂。后一发现表明喹那普利和PAH在转运体上共享一个共同的结合位点。总体而言,结果表明喹那普利是肾BLMV中有机阴离子转运体的高亲和力抑制剂,并提示在近端肾小管细胞的基底外侧膜可能会与其他有机阴离子发生药物相互作用。